Private Market View

Mineralys

Drug Discovery

Last price · $/share
Implied valuation
Total raised
$238.0M
Last round
PIPE
Feb 2024
Valuation — not yet established

No valuation for Mineralys is on record yet — no priced round, mark, or trade has surfaced in our sources. Total raised ($238.0M) and the funding record below are the closest available signals.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
See the evidence behind this price
  • ·Post-money valuations for all 2 rounds
  • ·Watchlist + deal alerts for Mineralys
Create free account
No card required

Funding history

2 rounds
DateRoundRaisedPost-money
Feb 2024PIPE$120.0M
Jun 2022Early Stage VC (Series B)$118.0M

How Mineralys's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Mineralys, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →

Frequently asked

How much has Mineralys raised?
Mineralys has raised $238.0M in total funding across 2 recorded rounds.
When did Mineralys last raise?
Mineralys last raised in Feb 2024 (PIPE), raising $120.0M.